[Application value of thromboelastography in assessing coagulation function in children with severe hemophilia A after emicizumab therapy: a single-center study].
The bleeding condition of children with severe HA can be effectively controlled after EMI treatment. Routine APTT testing cannot reflect true coagulation function, whereas TEG testing is clinically valuable in assessing the coagulation function of children with severe HA undergoing EMI treatment.
Authors
- Xiaoying Fu (ORCID: https://orcid.org/0000-0003-4210-3510)
- Guichi Zhou (ORCID: https://orcid.org/0009-0007-4854-1462)
- Liping Luo (ORCID: https://orcid.org/0000-0002-5649-1289)
- Yehong Kuang (ORCID: https://orcid.org/0000-0002-1133-1791)
- Meizhu Luo
- Qian Li (ORCID: https://orcid.org/0000-0001-5359-8534)
- Ying Wang (ORCID: https://orcid.org/0000-0003-0711-0854)
- Dong Peng (ORCID: https://orcid.org/0000-0001-5906-3303)
Institutions
- Shenzhen Children's Hospital (CN)
Publication Details
- Journal
- PubMed
- Published
- 2025-03-15
- DOI
- https://doi.org/10.7499/j.issn.1008-8830.2409099
- Primary Topic
- Hemophilia Treatment and Research
- Type
- article